Pfizer (NYSE:PFE) has completed the acquisition of Excaliard Pharmaceuticals.
Pfizer (NYSE:PFE) Completes Pharma Buy
According to an announcement made by the drug maker giant Pfizer (NYSE:PFE), it has completely acquired privately owned biopharmaceutical company Excaliard Pharmaceuticals, which is focused on developing novel drugs for the treatment of skin fibrosis, more commonly referred to as skin scarring.
Pfizer (NYSE:PFE) said in a statement, “At Pfizer, we apply science and our global resources to improve health and well-being at every stage of life. We strive to set the standard for quality, safety and value in the discovery, development and manufacturing of medicines for people and animals.”
Pfizer Inc. (NYSE:PFE) stocks are currently standing at 20.23.